EXPRESSION OF CIRCULAR RNA HSA_CIRC_0067705 IN MALIGNANT VERSUS NON MALIGNANT PLEURAL EFFUSION IN A COHORT OF EGYPTIAN PATIENTS
Zaghloul, R., Sharaki, O., Baeis, A., Ali, E., AbdAllah Youssuf Kandil, A. (2023). EXPRESSION OF CIRCULAR RNA HSA_CIRC_0067705 IN MALIGNANT VERSUS NON MALIGNANT PLEURAL EFFUSION IN A COHORT OF EGYPTIAN PATIENTS. EKB Journal Management System, 5(2), 6-7. doi: 10.21608/alexpo.2023.204858.1602
Raghda Saad Zaghloul; Ola Atef Sharaki; Ayman Baeis; Eman Sheta Ali; Amira Aly AbdAllah Youssuf Kandil. "EXPRESSION OF CIRCULAR RNA HSA_CIRC_0067705 IN MALIGNANT VERSUS NON MALIGNANT PLEURAL EFFUSION IN A COHORT OF EGYPTIAN PATIENTS". EKB Journal Management System, 5, 2, 2023, 6-7. doi: 10.21608/alexpo.2023.204858.1602
Zaghloul, R., Sharaki, O., Baeis, A., Ali, E., AbdAllah Youssuf Kandil, A. (2023). 'EXPRESSION OF CIRCULAR RNA HSA_CIRC_0067705 IN MALIGNANT VERSUS NON MALIGNANT PLEURAL EFFUSION IN A COHORT OF EGYPTIAN PATIENTS', EKB Journal Management System, 5(2), pp. 6-7. doi: 10.21608/alexpo.2023.204858.1602
Zaghloul, R., Sharaki, O., Baeis, A., Ali, E., AbdAllah Youssuf Kandil, A. EXPRESSION OF CIRCULAR RNA HSA_CIRC_0067705 IN MALIGNANT VERSUS NON MALIGNANT PLEURAL EFFUSION IN A COHORT OF EGYPTIAN PATIENTS. EKB Journal Management System, 2023; 5(2): 6-7. doi: 10.21608/alexpo.2023.204858.1602

EXPRESSION OF CIRCULAR RNA HSA_CIRC_0067705 IN MALIGNANT VERSUS NON MALIGNANT PLEURAL EFFUSION IN A COHORT OF EGYPTIAN PATIENTS

ALEXMED ePosters
Article 1, Volume 5, Issue 2, April 2023, Page 6-7  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.204858.1602
View on SCiNiTO View on SCiNiTO
Authors
Raghda Saad Zaghloul1; Ola Atef Sharaki2; Ayman Baeis3; Eman Sheta Ali4; Amira Aly AbdAllah Youssuf Kandil email 5
1Department of Clinical & chemical Patholohy**, Faculty of Medicine, Alexandria University, Egypt
2Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Egypt.
3Department Pulmonology , Faculty Of Medicine , Alexandria University
4Department of Pathology, Alexandria Faculty of Medicine, Alexandria University
5Clinical and Chemical Pathology Department, Faculty Of Medicine , Alexandria University.
Abstract
Introduction:
Malignant pleural effusion (MPE) is a frequent complication of many malignancies, with lung cancer being the most frequent etiology. Non-small cell lung cancer (NSCLC) is the most prevalent type and accounts for 85% of lung cancer cases. The presence of MPE in NSCLCpatients denotes an end-stage disease with reduced overall survival.Pleural biopsy remains the gold standard diagnostic tool. However, it’s considered invasive.Consequently, it’s important to identify a pleural fluid biomarker for NSCLC diagnosis. Epigenetic disruptions were linked to NSCLC via oncogene activation or tumor suppressor gene silencing. Circ RNAshave emerged as a class of non-coding RNAs (ncRNAs), which are known as epigenetic modifiers. Circ RNAsare covalently closed loop structure confers them the resistance to RNasescompared to linear RNAs. They are abundantly expressed, withtissue specific patterns. They play role in tumor progression through different regulatory mechanisms such as miRNAs sponging activity and circRNA protein interactions.hsa_circ_0067705 a novel circRNA was found to be up regulated in NSCLC-MPE patients. Thus, it might be involved in NSCLC progression, however, the detailed mechanism and the expression pattern in NSCLC-MPE remainelusive.
Keywords
MALIGNANT PLEURAL EFFUSION; CIRCULAR RNA; NSCLC
Supplementary Files
Statistics
Article View: 41